CA

CHI Advisors Portfolio holdings

AUM $252M
This Quarter Return
-12.68%
1 Year Return
+57.46%
3 Year Return
+78.52%
5 Year Return
10 Year Return
AUM
$430M
AUM Growth
+$430M
Cap. Flow
+$16.6M
Cap. Flow %
3.85%
Top 10 Hldgs %
90.74%
Holding
22
New
1
Increased
4
Reduced
8
Closed
4
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RPTX icon
1
Repare Therapeutics
RPTX
$71.7M
$79.2M 18.42% 2,539,644 -21,059 -0.8% -$657K
RXDX
2
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$70M 16.29% 2,852,009 -22,023 -0.8% -$541K
PLRX icon
3
Pliant Therapeutics
PLRX
$101M
$69M 16.04% 2,367,888 +43,093 +2% +$1.25M
CGEM icon
4
Cullinan Oncology
CGEM
$445M
$57.8M 13.44% 2,242,841 +40,434 +2% +$1.04M
VECT
5
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$30.2M 7.01% +2,585,986 New +$30.2M
ONCR
6
DELISTED
Oncorus, Inc.
ONCR
$24M 5.57% 1,735,979 -35,807 -2% -$494K
ORTX
7
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$17.9M 4.17% 4,081,972 +30,000 +0.7% +$132K
INZY
8
DELISTED
Inozyme Pharma
INZY
$15.8M 3.68% 927,264
LRMR icon
9
Larimar Therapeutics
LRMR
$310M
$14.9M 3.46% 1,515,148
IMA
10
ImageneBio, Inc. Common Stock
IMA
$150M
$11.4M 2.66% 814,756
FRLN
11
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$11.2M 2.62% 1,379,843 -4,900 -0.4% -$39.9K
AKUS
12
DELISTED
Akouos, Inc. Common Stock
AKUS
$10.8M 2.5% 858,027
DTIL icon
13
Precision BioSciences
DTIL
$57.8M
$8.16M 1.9% 651,729 -39,900 -6% -$500K
KROS icon
14
Keros Therapeutics
KROS
$618M
$4.94M 1.15% 116,406 -284,062 -71% -$12.1M
CRVS icon
15
Corvus Pharmaceuticals
CRVS
$428M
$1.92M 0.45% 719,132 +40,000 +6% +$107K
GTHX
16
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1.1M 0.26% 50,000
OVID icon
17
Ovid Therapeutics
OVID
$91M
$854K 0.2% 218,510 -29,000 -12% -$113K
KZR icon
18
Kezar Life Sciences
KZR
$28.9M
$796K 0.19% 146,680 -27,489 -16% -$149K
ADVM icon
19
Adverum Biotechnologies
ADVM
$64.6M
-40,209 Closed -$396K
BPMC
20
DELISTED
Blueprint Medicines
BPMC
-3,500 Closed -$340K
RARE icon
21
Ultragenyx Pharmaceutical
RARE
$2.89B
-2,000 Closed -$228K
GBT
22
DELISTED
Global Blood Therapeutics, Inc.
GBT
-15,000 Closed -$611K